Medicament for treating primary bronchogenic carcinoma
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A bronchial lung cancer, primary technology, applied in the direction of drug combination, pharmaceutical formula, medical raw materials derived from mammals, etc., can solve the problems of high price, low cure rate, unattainable treatment plan, etc., and achieves quick effect and non-toxicity. Side effects, the effect of easy preparation of drugs
Inactive Publication Date: 2013-06-26
李运乃
View PDF2 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Problems exist. The diagnosis and treatment of lung cancer patients mostly adopt traditional Western medicine treatment schemes, emerging interventional treatment and biological treatment, etc. The cure rate of these treatment methods is too low and the price is relatively expensive.
Based on the theory of traditional Chinese medicine, Dr. Yu set up the green treatment concept of using pure traditional Chinese medicine to strengthen the body and dispel pathogens, eliminate cancer poison, and both attack and supplement. The patient has brought great confidence, and there is no harm to the patient's body during the treatment process, these are the medical effects that cannot be achieved by the treatment options currently on the market
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0013] Embodiments are described in detail below:
[0014] Method 1. Set up and develop a small batch of medical compound lung cancer capsules. Take 20g of ginseng, 30g of astragalus, 30g of Hedyotis diffusa, 20g of cat’s claw, 3g of saffron, 6g of Panax notoginseng powder, 0.15g of musk, 15g of lobelia, Curcuma 15g, Lingxiaohua 10g, Cyperus cyperi 10g, peach kernel 10g, Zhizhizi 10g, gecko 30g, cordyceps sinensis 20g, broken ganoderma lucidum spore powder 30g, Chinese medicinal materials and packaging materials. It is a kind of drug preparation for treating primary bronchial lung cancer by taking appropriate amount of ingredients of traditional Chinese medicine, through authentic selection of materials, conventional processing, drying and drying on low heat, and packing into a small bag of raw materials for treating primary bronchial lung cancer. The raw materials in bags are processed and pulverized into 120-mesh fine powder by a small electric pulverizer, and then processed...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicament for treating primary bronchogenic carcinoma. Compound lung cancer capsule preparation consists of the following traditional Chinese medicines and packaging materials: ginseng, astragalus mongholicus, oldenlandia diffusa, ternate buttercup root, saffron crocus, pseudo-ginseng powder, musk, Chinese lobelia, curcuma zedoary, campsis grandiflora, rhizoma cyperi, peach kernel, akebia fruit, wall gecko, cordyceps sinensis and reishi shell-broken spore powder. The medicament disclosed by the invention fills up the blank in the subject filed for preventing and treating primary bronchogenic carcinoma-caused cough, hemoptysis, chest pain, phlegm and retained fluid, phlegm poison, lung poison, lung atelectasis, lung lump, lung accumulation and rushing respiration as well as pulmonary respiration-pulmonary atelectasis-caused deficiency of vital energy, imbalance of yin and yang, lung attacks due to deficiency of vital energy, qi depression of lung, disturbance of diffusion and downbearing, qi stagnation and blood stasis, phlegm cementation and lung cancers caused by lasting lung diseases. The medicament is innovative for the existing Chinese medicine treatment of the human in the world to lung cancer recovery clinical care culture.
Description
technical field [0001] The invention belongs to a medicine for treating primary bronchial lung cancer, that is, a compound lung cancer capsule preparation. Background technique [0002] Primary bronchial lung cancer, referred to as lung cancer, refers to malignant tumors that originate in bronchial mucosa and alveoli, and is one of the most common malignant tumors. According to authoritative data statistics compiled by the old man and published for the first time in January 1996, the male standardized mortality rate was 10.3 / 100,000, the fourth malignant tumor; the female standardized mortality rate was 4.8 / 100,000. It is the fifth malignant tumor. The disease is more likely to occur in men over the age of 40 who have a long-term smoking history, and exposure to carcinogens (such as arsenic, asbestos, chromium, nickel, coal tar, asphalt smoke, dichloromethyl ether, chloromethyl ether, etc.) , formaldehyde, dust, etc.), ionizing radiation, water pollution, air pollution, ge...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.